Skip to main content

Health condition

Germ cell tumours, seminoma, non-seminoma and the specialist care that cures most of them.

Uncommon but highly curable cancers of young men, young women and, more rarely, children. Modern chemotherapy and specialist surgery give overall cure rates of 90 to 95 per cent.

Jump to treatment
A radiographer guides a patient onto the bed of an advanced 3 Tesla MRI scanner in a London imaging suite

Why trust this guide

  • 01

    Editorial team

    Written by our editorial team from the UK sources listed on each page.

  • 02

    Sourced from guidance

    Checked against NICE, NHS England specialist commissioning and peer-reviewed oncology sources.

  • 03

    Current for 2026

    Reflects modern UK guidance including BEP chemotherapy, AYA pathways and specialist commissioned centres.

Key facts

Germ cell tumours at a glance.

The essentials, in plain English. Where they arise, how they behave, and why they are among the most curable cancers in modern oncology.

  • What they are

    Tumours arising from primordial germ cells. Most are gonadal (testicular or ovarian); a minority are extragonadal along the embryonal midline.

  • Testicular GCT

    The commonest cancer in men aged 15 to 35 and one of the most curable solid cancers. See our dedicated testicular cancer guide.

  • Ovarian GCT

    Around 5 per cent of ovarian cancers, typically in young women. Fertility-sparing surgery is usually possible.

  • Extragonadal sites

    Mediastinum, retroperitoneum, pineal, suprasellar (in children) and sacrococcygeal (in infants).

  • Two big groups

    Seminoma (or dysgerminoma in the ovary, germinoma in the CNS) and non-seminoma. They behave and are treated differently.

  • Highly curable

    Overall cure rates reach 90 to 95 per cent with modern BEP chemotherapy, specialist surgery and salvage protocols.

Why this guide matters

Uncommon cancers, specialist pathways.

Germ cell tumours are rare enough that they need specialist commissioned care and common enough in young adults that fast, correct routing matters more than any single test.

  • Markers guide the plan

    AFP, beta-hCG and LDH classify the tumour, define prognostic risk and follow response. In germ cell disease, they carry as much weight as imaging.

  • BEP is the workhorse

    Bleomycin, etoposide and cisplatin, given in three or four cycles, cures most metastatic disease. It is delivered in specialist centres with strict monitoring.

  • Fertility comes first

    Sperm banking, egg and ovarian tissue preservation should be arranged before chemotherapy or gonadal surgery, never after.

How the diagnosis is made

From first symptom to a specialist plan.

The UK pathway a young man, woman or child will normally follow, from presentation through markers, imaging and MDT to a treatment plan.

  1. 01

    Assessing

    Presentation and examination

    A testicular lump, ovarian mass, mediastinal shadow on imaging, or neurological signs from a pineal or suprasellar lesion.

  2. 02

    Assessing

    Tumour markers

    AFP, beta-hCG and LDH. Pure seminoma shows normal AFP with at most mildly raised hCG; any AFP rise implies a non-seminomatous component.

  3. 03

    Assessing

    Imaging

    Ultrasound for gonadal disease; CT chest, abdomen and pelvis for staging; MRI brain and spine where CNS disease is suspected.

  4. 04

    Confirming

    Histology

    Orchidectomy for testicular disease, oophorectomy or biopsy for ovarian and extragonadal disease, with expert germ-cell pathology review.

  5. 05

    Confirming

    Specialist MDT

    Discussion at a specialist commissioned GCT centre such as the Royal Marsden, Christie or UCLH, with AYA input where relevant.

  6. 06

    Preparing

    Fertility preservation

    Sperm banking, egg or ovarian tissue preservation before any chemotherapy or gonadal surgery.

  7. 07

    Preparing

    Baseline organ function

    Renal function, pulmonary function tests and audiometry before bleomycin and cisplatin-based chemotherapy.

Typical timeline: from presentation to a specialist plan within days to a couple of weeks.

Symptoms

How germ cell tumours present.

Presentation depends on where the tumour arises. Testicular disease is felt as a lump; extragonadal disease can hide in the chest, abdomen or brain until markers or imaging give it away.

  • Testicular lump or swelling

    A painless, firm testicular mass in a young man. See our dedicated testicular cancer guide for the full pathway.

  • Ovarian mass and abdominal pain

    A rapidly growing pelvic mass in a young woman, sometimes with torsion, rupture or ascites.

  • Mediastinal symptoms

    Chest pain, dyspnoea, cough or superior vena cava obstruction from a mediastinal germ cell tumour.

  • Retroperitoneal disease

    Back pain, abdominal fullness, leg swelling or renal impairment from bulky nodal or retroperitoneal disease.

  • Pineal and suprasellar signs

    Parinaud syndrome, hydrocephalus, diabetes insipidus or growth failure in children with intracranial germinomas.

  • Endocrine features

    Precocious puberty in children or gynaecomastia in adults from beta-hCG-secreting tumours.

  • Constitutional symptoms

    Weight loss, fatigue and breathlessness where pulmonary metastases are present.

  • Red flag - poor-risk disease

    Very high markers, mediastinal primary or non-pulmonary visceral metastases mean urgent transfer to a specialist commissioned centre.

Treatment

How germ cell tumours are treated in the UK.

Surgery, surveillance and BEP chemotherapy for most; radiotherapy in selected seminoma and CNS disease; RPLND and high-dose salvage transplant at specialist commissioned centres.

  • Orchidectomy

    Inguinal orchidectomy is the diagnostic and often curative first step for testicular germ cell tumours.

  • Fertility-sparing ovarian surgery

    Unilateral salpingo-oophorectomy with staging usually preserves the other ovary and uterus in young women.

  • Surveillance

    Stage I seminoma or non-seminoma with favourable features can be safely followed with markers and imaging in a specialist clinic.

  • Adjuvant carboplatin

    A single cycle of carboplatin is a standard adjuvant option for stage I seminoma at higher risk of relapse.

  • Para-aortic radiotherapy

    A selective option for stage IIA or IIB seminoma at specialist centres.

  • BEP chemotherapy

    Bleomycin, etoposide and cisplatin for three or four cycles is the backbone of treatment for metastatic and advanced disease.

  • Retroperitoneal lymph node dissection

    RPLND is used for residual masses after chemotherapy in non-seminoma, performed only in specialist commissioned centres.

  • Salvage and stem cell transplant

    TIP salvage chemotherapy and high-dose chemotherapy with autologous stem cell transplant for relapsed disease.

What this guide is based on

The sources behind every claim on this page.

UK national guidance, NHS England specialist commissioning specifications and international oncology standards, current at the time of last review.

Key references

Guidelines and standards we relied on.

A quiet reminder

This guide is for information, not medical advice.

Your oncology team knows your case in detail and can tell you which parts of this guide apply to you. If in doubt, get seen.

  • NICE guidance and quality standards on testicular and germ cell tumours.

  • NHS England service specifications for testicular cancer and specialist commissioned germ cell services.

  • European Society for Medical Oncology (ESMO). Testicular seminoma and non-seminoma clinical practice guidelines.

  • Teenage Cancer Trust and Macmillan Cancer Support patient guidance on germ cell cancers.

Red flags

When germ cell disease needs urgent attention.

Most patients are managed on scheduled protocols. These are the situations where the pace has to change, and where a specialist commissioned centre should be involved the same day.

  • Superior vena cava obstruction

    Facial swelling, plethora and distended neck veins in a young patient with a mediastinal mass need urgent oncology assessment.

  • Very high tumour markers

    AFP over 10,000, hCG over 50,000 or LDH more than 10 times normal define poor-risk disease and warrant same-day specialist transfer.

  • Brain metastases

    Headache, seizures or focal neurology in a patient with known GCT needs urgent MRI and specialist neuro-oncology input.

  • Choriocarcinoma syndrome

    Massive haemorrhage from pulmonary or intracranial metastases in high hCG choriocarcinoma is a medical emergency.

  • Bleomycin lung toxicity

    New cough, breathlessness or hypoxia during or after BEP chemotherapy requires prompt review and stopping bleomycin.

  • Neutropenic sepsis

    Fever within 10 days of chemotherapy is an emergency and needs antibiotics within one hour.

  • Hydrocephalus from a pineal lesion

    Headache, vomiting and reduced conscious level in a child with a pineal germinoma needs urgent neurosurgical review.

  • Fertility not addressed

    Any patient about to start chemotherapy or gonadal surgery who has not been offered fertility preservation should be paused and referred.

  • Late relapse

    Symptoms or rising markers more than two years after treatment need specialist review; late-relapse GCT behaves differently.

Living with it

A curable cancer, with a life to build after it.

Four themes shape survivorship: fertility protected up front, structured follow-up, AYA-tuned support, and long-term care for late effects.

A quiet reminder

Most people go on to live long, full lives.

Germ cell tumours are among the great success stories of modern oncology. The work is protecting fertility, catching relapse early and treating the late effects that come with cure.

  1. 01 Fertility

    Preserve it before treatment

    Sperm banking and egg or ovarian tissue preservation should be discussed before chemotherapy or gonadal surgery, not after.

  2. 02 Follow-up

    Markers and imaging for years

    Structured follow-up with tumour markers and imaging continues for at least five years, with intensity tapering over time.

  3. 03 AYA

    Teenage and young adult care

    Care in a Teenage Cancer Trust unit or AYA service supports school, work, relationships and mental health alongside treatment.

  4. 04 Late effects

    Cardiovascular and endocrine

    Long-term monitoring for cardiovascular disease, hypogonadism, secondary cancers and hearing loss is part of survivorship.

Frequently asked

Everything we get asked about germ cell tumours.

Quick answers on seminoma versus non-seminoma, tumour markers, BEP chemotherapy and fertility.

  • What is a germ cell tumour?

    A tumour that arises from primordial germ cells, which are the cells that normally form eggs and sperm. Most germ cell tumours occur in the testis or ovary, but they can also arise along the midline in the mediastinum, retroperitoneum or brain (pineal and suprasellar regions).

  • What is the difference between seminoma and non-seminoma?

    Seminoma is a slower-growing pure germ cell tumour with a normal AFP and at most mildly raised hCG. Non-seminoma includes embryonal carcinoma, yolk sac tumour, choriocarcinoma, teratoma and mixed tumours; it often produces higher markers and is treated with slightly different chemotherapy and surgical strategies. Any raised AFP means the tumour is treated as non-seminomatous.

  • Why are tumour markers so important?

    AFP, beta-hCG and LDH help classify the tumour, guide chemotherapy choice, define prognostic risk and monitor response and relapse. In germ cell tumours, markers can be more informative than imaging in the weeks after treatment.

  • How curable are germ cell tumours?

    They are among the most curable solid cancers. Overall cure rates reach 90 to 95 per cent with modern BEP chemotherapy, expert surgery for residual disease and salvage protocols including high-dose chemotherapy with autologous stem cell transplant for relapse.

  • Where should germ cell tumours be treated?

    At a specialist commissioned germ cell centre such as the Royal Marsden, Christie or UCLH, with input from testicular or gynaecological oncology, neuro-oncology for CNS disease, AYA services and a fertility team. Retroperitoneal lymph node dissection and salvage transplant care are only delivered in specialist commissioned centres.

  • Will treatment affect my fertility?

    It can. Chemotherapy, radiotherapy and gonadal surgery can all impair fertility. Sperm banking for men, and egg or ovarian tissue preservation for women, should be discussed and arranged before treatment starts wherever possible. A fertility specialist is a core member of the MDT.

Related content

Keep reading.